(Q53834924)
Statements
Clinical Utility of Patient-Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung Adenocarcinoma (English)
Dennis Wang
Thomas K Waddell
Erin L Stewart
Celine Mascaux
Nhu-An Pham
Shingo Sakashita
Jenna Sykes
Lucia Kim
Naoki Yanagawa
Kota Ishizawa
Chang-Qi Zhu
Ming Li
Christine Ng
Ni Liu
Melania Pintilie
Petra Martin
Natasha B Leighl
Benjamin G Neel
Frances A Shepherd
1 reference